Chemed Corporation Receives 'Hold' Rating from Analysts

Analysts cite mixed outlook on company's future performance

Published on Mar. 2, 2026

Got story updates? Submit your updates here. ›

Chemed Corporation (NYSE:CHE), a diversified provider of essential home services and healthcare solutions, has received a consensus 'Hold' rating from six research analysts covering the firm. While four analysts have rated the stock as 'Hold', two have issued 'Buy' recommendations. The average 12-month price target among the analysts is $498.00.

Why it matters

Chemed's mixed analyst ratings and price target adjustments reflect uncertainty around the company's near-term performance and execution of transition initiatives. As a diversified provider of essential services, Chemed's financial results and outlook are closely watched by investors seeking stability in the current market environment.

The details

The analysts' ratings and price target changes for Chemed Corporation came after the company reported fourth-quarter financial results that missed consensus estimates. Chemed reported Q4 earnings per share of $6.42, falling short of the expected $7.02. Revenue also came in below expectations at $639.34 million. The company cited margin compression and transition initiatives as factors impacting its performance. Looking ahead, Chemed provided fiscal year 2026 earnings guidance of $23.25 to $24.25 per share, with approximately 55% of earnings expected to be weighted to the back half of the year.

  • Chemed reported Q4 2025 financial results on February 25, 2026.
  • Chemed provided fiscal year 2026 earnings guidance on February 25, 2026.

The players

Chemed Corporation

A diversified provider of essential home services and healthcare solutions in the United States, headquartered in Cincinnati, Ohio.

Roto-Rooter

Chemed's segment that offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Vitas Healthcare

Chemed's healthcare segment that provides hospice and palliative care services.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee (Instagram)

The takeaway

Chemed's mixed analyst ratings and guidance reflect the challenges the company faces in navigating margin pressures and executing on transition initiatives. As a diversified provider of essential services, Chemed's performance will continue to be closely watched by investors seeking stability in the current market environment.